Literature DB >> 6102865

Comparison of oral triclofos, diazepam and flunitrazepam as premedicants in children undergoing otolaryngological surgery.

L Lindgren, L Saarnivaara, J J Himberg.   

Abstract

Triclofos 70 mg kg-1, diazepam 0.25 mg kg-1 and flunitrazepam 0.02 mg kg-1 all in combination with atropine 0.03 mg kg-1 were compared as oral premedicants in 128 children undergoing otolaryngological surgery in a double-blind study. All drugs provided good anxiolysis in children 5 yr and older. In children less than 5 yr, the effects of triclofos were superior to those of diazepam and flunitrazepam. There was a positive correlation between anxiolysis and the ease of induction of anaesthesia. In both age groups, flunitrazepam prevented the fasciculations caused by suxamethonium more effectively than did diazepam or triclofos. The preinduction heart rate after triclofos was greater than after the other drugs and its antisialagogue effect was superior. The mean volume of gastric contents was 0.4 ml kg-1 for all the patients with no statistically significant difference between the groups. The mean pH of gastric contents was 4.5 after triclofos and 2.2 after other drugs. The serum concentration of both benzodiazepines in the older age group was greater than in the younger age group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102865     DOI: 10.1093/bja/52.3.283

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

2.  Induction, maintenance and recovery characteristics of desflurane in infants and children.

Authors:  R H Taylor; J Lerman
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

3.  Comparison of analgesic/sedative effect of racemic ketamine and S(+)-ketamine during cardiac catheterization in newborns and children.

Authors:  C Pees; N A Haas; P Ewert; F Berger; P E Lange
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.